Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk
暂无分享,去创建一个
Charles C. White | D. Reich | H. Weiner | L. Chibnik | P. D. Jager | T. Chitnis | P. Winn | M. Cimpean | S.U. Steele | I. Cortese | Zongqi Xia | C. McCabe | Sarah R. Clarkson | E. Owen | A. V. Korff | Ashley N. Hoesing
[1] A. Ascherio,et al. Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis , 2015, Multiple sclerosis.
[2] T. Olsson,et al. Obesity interacts with infectious mononucleosis in risk of multiple sclerosis , 2014, European journal of neurology.
[3] Daphne Koller,et al. Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.
[4] T. Olsson,et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis , 2014, Neurology.
[5] I. Yee,et al. The Prevalence of Familial Multiple Sclerosis in Saskatoon, Saskatchewan , 2014, Multiple sclerosis international.
[6] M. Ramanathan,et al. Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Patients with Multiple Sclerosis , 2014, American Journal of Neuroradiology.
[7] Peter Szolovits,et al. Modeling Disease Severity in Multiple Sclerosis Using Electronic Health Records , 2013, PloS one.
[8] M. Pirinen,et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.
[9] T. Sørensen,et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study , 2013, Multiple sclerosis.
[10] C. Koebnick,et al. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome , 2013, Neurology.
[11] J. Lünemann,et al. The initiation and prevention of multiple sclerosis , 2012, Nature Reviews Neurology.
[12] J. Haselkorn,et al. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. , 2012, Brain : a journal of neurology.
[13] D. Goodin,et al. Survival in MS , 2012, Neurology.
[14] T. Olsson,et al. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women , 2012, Multiple sclerosis.
[15] P. D. de Bakker,et al. Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci , 2011, Annals of neurology.
[16] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[17] T. Olsson,et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. , 2011, Brain : a journal of neurology.
[18] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[19] S. Hauser,et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families , 2011, Annals of neurology.
[20] J. Shulman,et al. A Putative Alzheimer's Disease Risk Allele in PCK1 Influences Brain Atrophy in Multiple Sclerosis , 2010, PloS one.
[21] P. Kraft,et al. Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk , 2010, Annals of the rheumatic diseases.
[22] Jing Cui,et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score , 2009, The Lancet Neurology.
[23] F. Moore. INCIDENTAL MRI ANOMALIES SUGGESTIVE OF MULTIPLE SCLEROSIS: THE RADIOLOGICALLY ISOLATED SYNDROME , 2009, Neurology.
[24] David H. Miller,et al. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial , 2009, The Lancet Neurology.
[25] F Fazekas,et al. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.
[26] T. Olsson,et al. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis , 2009, Neurology.
[27] Pablo Moscato,et al. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.
[28] Ludwig Kappos,et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.
[29] Michael R. Johnson,et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. , 2009, Human molecular genetics.
[30] G. Ebers. Environmental factors and multiple sclerosis , 2008, The Lancet Neurology.
[31] S. Gabriel,et al. Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.
[32] A. Ascherio,et al. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.
[33] A. Ascherio,et al. Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.
[34] V. Honti,et al. Epidemiology of familial multiple sclerosis in Hungary , 2007, Multiple sclerosis.
[35] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.
[36] M. Battaglini,et al. Imaging brain damage in first‐degree relatives of sporadic and familial multiple sclerosis , 2006, Annals of neurology.
[37] A. Ascherio,et al. Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis , 2006, Annals of neurology.
[38] M. Hernán,et al. Cigarette smoking and the progression of multiple sclerosis. , 2005, Brain : a journal of neurology.
[39] David H. Miller,et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.
[40] M. Hernán,et al. Multiple sclerosis and age at infection with common viruses. , 2001, Epidemiology.
[41] J. Udupa,et al. Familial multiple sclerosis: volumetric assessment in clinically symptomatic and asymptomatic individuals , 1999, Multiple sclerosis.
[42] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[43] M. Rewers,et al. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY) , 1996, Diabetologia.
[44] N. Risch,et al. A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.
[45] W. Smoker,et al. MRI in familial multiple sclerosis , 1990, Neurology.
[46] T. Engell. A clinical patho‐anatomical study of clinically silent multiple sclerosis , 1989, Acta neurologica Scandinavica.
[47] H. M. Baum,et al. The incidence and prevalence of reported multiple sclerosis , 1981, Annals of neurology.